Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 78

1.

Psychoactive drug prescription and urine colonization with extended-spectrum β-lactamase-producing Enterobacteriaceae.

Bachtarzi R, Boureau AS, Mascart C, Batard E, Montassier E, Bémer P, Bourigault C, Berrut G, de Decker L, Chapelet G.

Infect Drug Resist. 2019 Jun 28;12:1763-1770. doi: 10.2147/IDR.S200029. eCollection 2019.

2.

Probabilistic chemotherapy in knee and hip replacement infection: the place of linezolid.

Deroche L, Plouzeau C, Bémer P, Tandé D, Valentin AS, Jolivet-Gougeon A, Lemarié C, Bret L, Kempf M, Héry-Arnaud G, Corvec S, Burucoa C, Arvieux C, Bernard L; and the CRIOGO (Centre de Référence des Infections Ostéo-articulaires du Grand Ouest) Study Group.

Eur J Clin Microbiol Infect Dis. 2019 Sep;38(9):1659-1663. doi: 10.1007/s10096-019-03594-z. Epub 2019 Jun 15.

PMID:
31203474
3.

Prevalence of Haemophilus influenzae with alteration of PBP 3 sequence over a 1-year period in a French hospital: focus on a clinical failure after ceftriaxone treatment.

Thomas E, Guillouzouic A, Juvin ME, Chene AL, Caillon J, Bémer P, Corvec S.

Diagn Microbiol Infect Dis. 2019 Feb;93(2):89-91. doi: 10.1016/j.diagmicrobio.2018.08.013. Epub 2018 Sep 1.

PMID:
30249513
4.

Bio-Electro-Magnetic-Energy-Regulation (BEMER) for the treatment of type I complex regional pain syndrome: A pilot study.

Benedetti MG, Cavazzuti L, Mosca M, Fusaro I, Zati A.

Physiother Theory Pract. 2018 Jul 9:1-9. doi: 10.1080/09593985.2018.1491661. [Epub ahead of print]

PMID:
29985719
5.

Characteristics and outcome of multidrug-resistant tuberculosis in a low-incidence area.

Gaborit BJ, Revest M, Roblot F, Maakaroun-Vermesse Z, Bemer P, Guimard T, Raffi F, Bourigault C, Boutoille D; GERICCO MDR-TB study group.

Med Mal Infect. 2018 Oct;48(7):457-464. doi: 10.1016/j.medmal.2018.04.400. Epub 2018 Jun 7.

PMID:
29887187
6.

Negative role of malnutrition in cell-mediated immune response: Pneumocystis jirovecii pneumonia (PCP) in a severely malnourished, HIV-negative patient with anorexia nervosa.

Hanachi M, Bohem V, Bemer P, Kayser N, de Truchis P, Melchior JC.

Clin Nutr ESPEN. 2018 Jun;25:163-165. doi: 10.1016/j.clnesp.2018.03.121. Epub 2018 Apr 13.

PMID:
29779813
7.

Bacteriological relevance of linezolid vs. vancomycin in postoperative empirical treatment of osteoarticular infections: a retrospective single-center study.

Takoudju E, Bémer P, Touchais S, Asseray N, Corvec S, Khatchatourian L, Serandour N, Boutoille D; Nantes Bone and Joint Infections Study Group.

Int J Antimicrob Agents. 2018 Nov;52(5):663-666. doi: 10.1016/j.ijantimicag.2018.04.022. Epub 2018 May 9.

PMID:
29751119
8.

Pulsed electromagnetic field therapy in the treatment of pain and other symptoms in fibromyalgia: A randomized controlled study.

Multanen J, Häkkinen A, Heikkinen P, Kautiainen H, Mustalampi S, Ylinen J.

Bioelectromagnetics. 2018 Jul;39(5):405-413. doi: 10.1002/bem.22127. Epub 2018 Apr 30.

PMID:
29709070
9.

Multi-drug-resistant Enterobacteriacae carriage in highly exposed nursing homes: prevalence in western France.

Birgand G, Hayatgheib N, Bémer P, Guilloteau V, Legeay C, Perron S, Chapelet G, Corvec S, Bourigault C, Batard E, Lepelletier D; MiHAR study group.

J Hosp Infect. 2017 Nov;97(3):258-259. doi: 10.1016/j.jhin.2017.07.032. Epub 2017 Aug 1. No abstract available.

PMID:
28774743
10.

Salvage therapy for complex bone and joint infections with ceftaroline: a multicentre, observational study.

Malandain D, Dinh A, Ferry T, Touchais S, Lustig S, Laurent F, Corvec S, Bémer P, Asseray N, Boutoille D.

Int J Antimicrob Agents. 2017 Aug;50(2):277-280. doi: 10.1016/j.ijantimicag.2017.05.021. Epub 2017 Jul 6. No abstract available.

PMID:
28689872
11.

Assessment of the automated multiplex-PCR Unyvero i60 ITI® cartridge system to diagnose prosthetic joint infection: a multicentre study.

Malandain D, Bémer P, Leroy AG, Léger J, Plouzeau C, Valentin AS, Jolivet-Gougeon A, Tandé D, Héry-Arnaud G, Lemarié C, Kempf M, Bret L, Burucoa C, Corvec S; Centre de Référence des Infections Ostéo-articulaires du Grand Ouest (CRIOGO) Study Team.

Clin Microbiol Infect. 2018 Jan;24(1):83.e1-83.e6. doi: 10.1016/j.cmi.2017.05.017. Epub 2017 May 27.

12.

Draft Genome Sequences of Four Propionibacterium acnes Strains Isolated from Implant-Related Infections.

Aubin GG, Kambarev S, Guillouzouic A, Lepelletier D, Bémer P, Corvec S.

Genome Announc. 2016 Dec 15;4(6). pii: e01395-16. doi: 10.1128/genomeA.01395-16.

13.

BEMER Electromagnetic Field Therapy Reduces Cancer Cell Radioresistance by Enhanced ROS Formation and Induced DNA Damage.

Storch K, Dickreuter E, Artati A, Adamski J, Cordes N.

PLoS One. 2016 Dec 13;11(12):e0167931. doi: 10.1371/journal.pone.0167931. eCollection 2016.

14.

Is there an association between prior anti-inflammatory drug exposure and occurrence of peritonsillar abscess (PTA)? A national multicenter prospective observational case-control study.

Lepelletier D, Pinaud V, Le Conte P, Bourigault C, Asseray N, Ballereau F, Caillon J, Ferron C, Righini C, Batard E, Potel G; French PTA Study Group.

Eur J Clin Microbiol Infect Dis. 2017 Jan;36(1):57-63. doi: 10.1007/s10096-016-2770-1. Epub 2016 Sep 7.

PMID:
27604832
15.

Draft Genome Sequence of Highly Rifampin-Resistant Propionibacterium namnetense NTS 31307302T Isolated from a Patient with a Bone Infection.

Aubin GG, Kambarev S, Bémer P, Lawson PA, Corvec S.

Genome Announc. 2016 Aug 11;4(4). pii: e00819-16. doi: 10.1128/genomeA.00819-16.

16.

Gram-negative prosthetic joint infections managed according to a multidisciplinary standardized approach: risk factors for failure and outcome with and without fluoroquinolones.

Grossi O, Asseray N, Bourigault C, Corvec S, Valette M, Navas D, Happi-Djeukou L, Touchais S, Bémer P, Boutoille D; Nantes Bone and Joint Infections Study Group.

J Antimicrob Chemother. 2016 Sep;71(9):2593-7. doi: 10.1093/jac/dkw202. Epub 2016 Jun 7.

PMID:
27278900
17.

Propionibacterium namnetense sp. nov., isolated from a human bone infection.

Aubin GG, Bémer P, Kambarev S, Patel NB, Lemenand O, Caillon J, Lawson PA, Corvec S.

Int J Syst Evol Microbiol. 2016 Sep;66(9):3393-3399. doi: 10.1099/ijsem.0.001204. Epub 2016 Jun 3.

PMID:
27259292
18.

Levofloxacin at the usual dosage to treat bone and joint infections: a cohort analysis.

Asseray N, Bourigault C, Boutoille D, Happi L, Touchais S, Corvec S, Bemer P, Navas D.

Int J Antimicrob Agents. 2016 Jun;47(6):478-81. doi: 10.1016/j.ijantimicag.2016.03.003. Epub 2016 Apr 22.

PMID:
27208901
19.

Failure of combination therapy for Staphylococcus aureus bone infection: a case of in vivo selection with resistance to rifampicin and fusidic acid.

Aubin GG, Bémer P, Guillouzouic A, Launay E, Geffroy L, Touchais S, Corvec S.

Infect Dis (Lond). 2016 Sep;48(9):699-702. doi: 10.1080/23744235.2016.1183815. Epub 2016 May 19.

PMID:
27194514
20.

Community-acquired Clostridium difficile infections.

Penit A, Bemer P, Besson J, Cazet L, Bourigault C, Juvin ME, Fix MH, Bruley des Varannes S, Boutoille D, Batard E, Lepelletier D.

Med Mal Infect. 2016 May;46(3):131-9. doi: 10.1016/j.medmal.2016.01.007. Epub 2016 Mar 30.

PMID:
27039068

Supplemental Content

Loading ...
Support Center